文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Crosstalk between mitochondrial dysfunction and benign prostatic hyperplasia: unraveling the intrinsic mechanisms.

作者信息

Liu Huan, Li Yan, Qiu Jizhang, Zhang Junchao, Lai Huan, Zhang Xinhua

机构信息

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.

Department of Urology, Xijing Hospital of Fourth Military Medical University, Xi'an, 710000, China.

出版信息

Can J Urol. 2025 Aug 29;32(4):255-269. doi: 10.32604/cju.2025.066523.


DOI:10.32604/cju.2025.066523
PMID:40910323
Abstract

Benign prostatic hyperplasia (BPH) represents a prevalent etiology of lower urinary tract symptoms (LUTS) in the male population, clinically defined by a non-malignant proliferation of prostatic tissue. While BPH exhibits a high prevalence among older male populations globally, the precise underlying mechanisms contributing to its development remain incompletely elucidated. Mitochondria, essential organelles within eukaryotic cells, are critical for cellular bioenergetics, the regulation of reactive oxygen species (ROS) generation, and the modulation of cell death pathways. The maintenance of mitochondrial homeostasis involves a complex interplay of processes. By synthesizing previous literature, this review discusses mitochondrial homeostasis in prostate glands and the role of mitochondrial dysfunction in the context of BPH. Furthermore, the review delved into each dimension of mitochondrial dysfunction in the specific etiology of BPH, highlighting its impact on cell survival, apoptosis, ferroptosis, oxidative stress and androgen receptor (AR). Overall, this review aims to unveil the crosstalk between mitochondrial dysfunction and BPH and identify intrinsic mechanisms.

摘要

相似文献

[1]
Crosstalk between mitochondrial dysfunction and benign prostatic hyperplasia: unraveling the intrinsic mechanisms.

Can J Urol. 2025-8-29

[2]
Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia.

J Gerontol A Biol Sci Med Sci. 2024-6-1

[3]
Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.

Prostate Cancer Prostatic Dis. 2022-3

[4]
Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial.

Trials. 2024-9-2

[5]
Pygeum africanum for benign prostatic hyperplasia.

Cochrane Database Syst Rev. 2002

[6]
Serenoa repens for benign prostatic hyperplasia.

Cochrane Database Syst Rev. 2012-12-12

[7]
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.

Cochrane Database Syst Rev. 2021-7-15

[8]
Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Cochrane Database Syst Rev. 2022-3-29

[9]
Safety and efficacy of an α -blocker plus mirabegron compared with an α -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis.

Neurourol Urodyn. 2024-3

[10]
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

J Sex Med. 2025-4-8

本文引用的文献

[1]
DNA damage response regulator ATR licenses PINK1-mediated mitophagy.

Nucleic Acids Res. 2025-2-27

[2]
Kirenol alleviates cerebral ischemia-reperfusion injury by reducing oxidative stress and ameliorating mitochondrial dysfunction via activating the CK2/AKT pathway.

Free Radic Biol Med. 2025-5

[3]
PPM1D ameliorates Alzheimer's disease by promoting mitophagy.

Exp Neurol. 2025-6

[4]
CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis.

Cell Death Dis. 2025-3-15

[5]
Artemetin targets the ABCG2/RAB7A axis to inhibit mitochondrial dysfunction in asthma.

Phytomedicine. 2025-5

[6]
ZnT6-mediated Zn redistribution: impact on mitochondrial fission and autophagy in H9c2 cells.

Mol Cell Biochem. 2025-3-14

[7]
Testes-specific protease 50 heightens stem-like properties and improves mitochondrial function in colorectal cancer.

Life Sci. 2025-6-1

[8]
AGTR1 potentiates the chemotherapeutic efficacy of cisplatin in esophageal carcinoma through elevation of intracellular Ca and induction of apoptosis.

Int J Oncol. 2025-4

[9]
National prevalence and incidence of benign prostatic hyperplasia/lower urinary tract symptoms and validated risk factors pattern.

Aging Male. 2025-12

[10]
TIMM23 overexpression drives NSCLC cell growth and survival by enhancing mitochondrial function.

Cell Death Dis. 2025-3-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索